Glimcare MV 1

CHEMICAL COMBINATION OF
Voglibose 0.3mg + Glimepiride 1mg + Metformin Hydrochlroide (as sustained release form) 500mg
PACKING
Strip of 10 tablets
USES
Treatment of type 2 diabetes mellitus.
BENEFITS :
Glimepiride + Metformin + Voglibose is used in the treatment of type 2 diabetes mellitus. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.
SIDE EFFECTS
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
common side effects

• Nausea
• Diarrhea